Effect of Cyclopiazonic Acid, an Inhibitor of the Sarcoplasmic Reticulum Ca-ATPase, on Skeletal Muscles from Normal and Mdx Mice
Overview
Physiology
Authors
Affiliations
Aim: In this study, we investigated Ca2+ loading by the sarcoplasmic reticulum in skeletal muscle from mdx mice, an animal model of human Duchenne's muscular dystrophy, at two stages of development: 4 and 11 weeks.
Method: Experiments were conducted on fast- (extensor digitorum longus, EDL) and slow- (soleus) twitch muscles expressing different isoforms of Ca2+-ATPase, which is responsible for the uptake of Ca2+ by the sarcoplasmic reticulum.
Results: In sarcoplasmic reticulum vesicles, the ATP-dependent activity and sensitivity to cyclopiazonic acid (CPA), an inhibitor of the sarcoplasmic reticulum Ca2+-ATPase, were similar in mdx and normal EDL muscle. Furthermore, in chemically-skinned fibres from both normal and mdx muscles, the presence of CPA induced a decrease in Ca2+ uptake by the sarcoplasmic reticulum. However, the sensitivity to CPA was lower in mdx EDL muscle than in normal muscle. In addition, in EDL muscle from 4-week-old mdx mice, the expression of the slow Ca2+-pump isoform (SERCA2a) was significantly increased, without any accompanying change in slow myosin expression. In contrast, the expression and function of the Ca2+-ATPase in mdx soleus muscles at 4- and 11-weeks of development did not differ from those in age-matched controls.
Conclusion: These findings show that in dystrophic muscle, where the Ca2+ homeostasis was perturbed, the Ca2+ handling by the sarcoplasmic reticulum was altered in fast-twitch muscle, and this was associated with the expression of the slow isoform of SERCA. In these muscles, reduced Ca2+ uptake could then contribute to an elevated concentration of Ca2+ in the cytosol, and also to Ca2+ depletion of the sarcoplasmic reticulum.
Garcia-Castaneda M, Michelucci A, Zhao N, Malik S, Dirksen R J Gen Physiol. 2022; 154(9).
PMID: 35939054 PMC: 9365874. DOI: 10.1085/jgp.202213081.
Mekies L, Regev D, Eisen B, Fernandez-Gracia J, Baskin P, Ben Jehuda R J Cell Mol Med. 2021; 25(8):3922-3934.
PMID: 33619882 PMC: 8051742. DOI: 10.1111/jcmm.16341.
Coccurello R, Volonte C Front Endocrinol (Lausanne). 2020; 11:199.
PMID: 32528404 PMC: 7247848. DOI: 10.3389/fendo.2020.00199.
Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy.
Bella P, Farini A, Banfi S, Parolini D, Tonna N, Meregalli M EMBO Mol Med. 2019; 12(1):e11019.
PMID: 31793167 PMC: 6949491. DOI: 10.15252/emmm.201911019.
Increase in phospholamban content in mouse skeletal muscle after denervation.
Komatsu M, Nakada T, Kawagishi H, Kato H, Yamada M J Muscle Res Cell Motil. 2019; 39(5-6):163-173.
PMID: 30806861 DOI: 10.1007/s10974-019-09504-2.